Research output per year
Research output per year
Personal profile
Expertises
Endocrinology and diabetes.
Main research areas
Type 2 diabetes; treatment, pathophysiology and metabolism.
Current research
Metabolism in prediabetics (psoriasis); treatment of diabetes (SGLT2 inhibitors), MODY.
Potential conflicts of interest
I have received lecture fees from AstraZeneca, Boehringer Ingelheim Pharmaceuticals and Bristol Myers Squibb and have participated in advisory boards for AstraZeneca and Boehringer Ingelheim Pharmaceuticals.
Fingerprint
Dive into the research topics where Heidi Storgaard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Effect of intensive nutrition training, education and support versus standard therapy in reducing the need for insulin therapy in gestational diabetes (INTENSE-GDM): a protocol for a randomised controlled single-centre trial in Denmark
Ewers, B., Blond, M. B., Kelstrup, L., Foghsgaard, S., Bergholt, T., Hansen, M. J., Storgaard, H., Holmager, P. & Mathiesen, E. R., 17 Feb 2025, In: BMJ Open. 15, 2, 12 p., e089231.Research output: Contribution to journal › Journal article › Research › peer-review
-
High-intensity interval training improves insulin sensitivity in individuals with prediabetes
Mensberg, P., Frandsen, C., Carl, C. S., Espersen, E., Leineweber, T., Larsen, E. L., Storgaard, H., Schlawitz, K., Petersen, T. H. D., Poulsen, J. N., Sørensen, F., Gørtz, P. M., Forman, J. L., Kiens, B., Knop, F. K. & Vilsbøll, T., 1 Apr 2025, In: European Journal of Endocrinology. 192, 4, p. 456-465 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Skin and systemic inflammation in adults with atopic dermatitis before and after whole-body topical betamethasone 17-valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study
Gether, L., Linares, H. P. I., Kezic, S., Jakasa, I., Forman, J., Sørensen, O. E., Storgaard, H., Skov, L., Røpke, M. A., Knop, F. K. & Thyssen, J. P., Feb 2025, In: Journal of the European Academy of Dermatology and Venereology : JEADV. 39, 2, p. 308-321 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Sass, M. R., Danielsen, A. A., Köhler-Forsberg, O., Storgaard, H., Knop, F. K., Nielsen, M. Ø., Sjödin, A. M., Mors, O., Correll, C. U., Ekstrøm, C., Vinberg, M., Nielsen, J., Vilsbøll, T. & Fink-Jensen, A., 31 Jan 2023, In: BMJ Open. 13, 1, p. e068652 e068652.Research output: Contribution to journal › Journal article › Research › peer-review
16 Citations (Scopus) -
Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis-A randomized controlled study
Gether, L., Storgaard, H., Kezic, S., Jakasa, I., Hartmann, B., Skov-Jeppesen, K., Holst, J. J., Pedersen, A. J., Forman, J., van Hall, G., Sørensen, O. E., Skov, L., Røpke, M. A., Knop, F. K. & Thyssen, J. P., Jul 2023, In: Allergy. 78, 7, p. 1964-1979 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
16 Citations (Scopus)